Morgan Stanley Maintains Equal-Weight on Tandem Diabetes Care, Raises Price Target to $25
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Patrick Wood maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and raises the price target from $23 to $25.
Morgan Stanley analyst Patrick Wood maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Equal-Weight and raises the price target from $23 to $25.